Search results
Results from the WOW.Com Content Network
Betamethasone is a steroid medication. [3] It is used for a number of diseases including rheumatic disorders such as rheumatoid arthritis and systemic lupus erythematosus, skin diseases such as dermatitis and psoriasis, allergic conditions such as asthma and angioedema, preterm labor to speed the development of the baby's lungs, Crohn's disease, cancers such as leukemia, and along with ...
Minor side effects include dry skin and mild, temporary stinging when applied. [3] Betamethasone dipropionate is a "super high potency" corticosteroid used to treat inflammatory skin conditions such as dermatitis, eczema and psoriasis. It is a synthetic analog of the adrenal corticosteroids.
Disodium pyrophosphate or sodium acid pyrophosphate (SAPP) [1] is an inorganic compound with the chemical formula Na 2 H 2 P 2 O 7. It consists of sodium cations ( Na + ) and dihydrogen pyrophosphate anions ( H 2 P 2 O 2− 7 ).
Disodium phosphate (DSP), or disodium hydrogen phosphate, or sodium phosphate dibasic, is an inorganic compound with the chemical formula Na 2 H P O 4. It is one of several sodium phosphates. The salt is known in anhydrous form as well as hydrates Na 2 HPO 4 ·nH 2 O, where n is 2, 7, 8, and 12. All are water-soluble white powders. The ...
Tetrasodium pyrophosphate, also called sodium pyrophosphate, tetrasodium phosphate or TSPP, is an inorganic compound with the formula Na 4 P 2 O 7. As a salt, it is a white, water-soluble solid. It is composed of pyrophosphate anion and sodium ions. Toxicity is approximately twice that of table salt when ingested orally. [3]
Whilst phosphate is present in the body and food in organic forms, inorganic forms of phosphate such as sodium triphosphate are readily adsorbed and can result in elevated phosphate levels in serum. [15] Salts of polyphosphate anions are moderately irritating to skin and mucous membranes because they are mildly alkaline. [1]
The process involves scission of a pyrophosphate bond, analogous to hydrolysis. SMFP can also be prepared by treating tetrasodium pyrophosphate or disodium phosphate with hydrogen fluoride. [2] In the laboratory, SMFP can be prepared by hydrolysis of difluorophosphate ions with dilute sodium hydroxide: PO 2 F 2 − + 2 NaOH → Na 2 PO 3 F + H ...
[15] [18] [19] [20] A 2017 Cochrane review found that for people with early breast cancer, bisphosphonate treatment may reduce the risk of the cancer spreading to the person's bone, however, for people who had advanced breast cancer bisphosphonate treatment did not appear to reduce the risk of the cancer spreading to the bone. [15]